SAN DIEGO, Nov. 23, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce the immediate release of its new line of Real Scientific Hemp Oil™ (RSHO™) products with medium-chain triglyceride (MCT) oil for import into Brazil, through its exclusive distributor HempMeds Brasil™. This new liquid product line is an all-natural, non-GMO hemp oil formulation with MCT oil.
“Convenience is key,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “After listening to our customers who are using RSHO™ hemp CBD oil, we discovered that many were blending RSHO™ with coconut and/or MCT oil to optimize the consistency when providing it to their children. With the new RSHO™ liquid formulation of MCT oil and convenient dosing spoon, we are simplifying administering the product. We are extremely excited and pleased with this new product line and feel that the popularity of RSHO™ will further expand, as a result of making it more convenient for consumers to use.”
The new RSHO™ liquid is now measured in milliliters. This will allow doctors to prescribe the liquid in a measured dosage they are more familiar with.
MCT oil is found naturally in popular food items, including coconut oil and is a top source of essential healthy fats that are popular with athletes, culinary experts and health and nutrition professionals worldwide, as explained by WebMD.
HempMeds Brasil™ is now making available three new, all-natural hemp oil products with MCT oil:
- Real Scientific Hemp Oil™ [RSHO™] new cannabidiol (CBD) liquid products with MCT oil in Gold.
- Real Scientific Hemp Oil™ [RSHO™] new cannabidiol (CBD) liquid products with MCT oil in Blue.
- Real Scientific Hemp Oil™ new cannabidiol (CBD) in convenient capsules.
Currently on a case-by-case basis, residents of Brazil who have a government-recognized medical indication and want access to RSHO™ hemp oil products, may do so with a doctor's prescription and formal import approval from ANVISA. The government agency also explains on its website how to apply for an import certificate. HempMeds Brasil™ has been preparing for more than a year, its formal product application and regulatory submission, a process which is expected to be completed by 2016.
In the U.S. hemp is widely regarded as a whole food and super-food. Medical Marijuana, Inc.'s cannabidiol (CBD) hemp oil is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic/euphoric effects of THC. Non-GMO RSHO™ contains no pesticides, herbicides or heavy metals. Before becoming a finished product, RSHO™ goes through multiple quality tests by top cannabis industry and food laboratories.
For additional information on the new RSHO™ MCT oil products available for import, visit the HempMeds Brasil™ website here.
About HempMeds Brasil™
HempMeds Brasil™ is a corporate affiliated company of Medical Marijuana, Inc. (OTC Pink: MJNA) and is its exclusive distributor of RSHO™. HempMeds Brasil™ offers specialized marketing, sales, customer service, and logistics to supply natural hemp oil rich in CBD to the medical community and families of Brazil. For more information on HempMeds Brasil™ and their all-natural hemp oil products, visit: http://www.hempmeds.com.br. The Company invites the public to get involved in the conversation on the expanding cannabis industry with HempMeds Brasil™ through the Company's social media channels Facebook, Twitter and blog.
About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact: Public Relations contact: Andrew Hard Chief Executive Officer CMW Media P. 858-264-6601 email@example.com www.cmwmedia.com Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc Investor Relations: GH Investment Advisors 550 West "C" Street, Ste. 2040 San Diego, CA 92101 Brian Barnes Office: (858) 264-6500 Toll Free: (877) 964-6463 firstname.lastname@example.org
Source:Medical Marijuana Inc